Web Press Release No. 215
Download PDF version of this document.

February 5, 2007

AMRI to Announce Fourth Quarter Results

Albany , NY (February 5, 2007)—Albany Molecular Research, Inc. (NASDAQ: AMRI) will report fourth quarter results before the opening of the market on Monday, February 12, 2007. The company will hold a conference call at 10:00 a.m. Eastern Time to discuss its quarterly financial results.

If you are interested in listening to the conference call, please dial 800-289-0726 (for domestic calls) or 913-981-5545 (for international calls) at 9:45 a.m. ET and provide conference code 4299861. In addition, the call is being webcast on the Internet and can be accessed on the company's website, www.albmolecular.com .

Replays of the call will be available for seven days following the call beginning at 12:00 p.m. on February 12, 2007. To access the replay by telephone, please call 888-203-1112 (for domestic calls) or 719-457-0820 (for international calls) and use passcode 4299861. In addition, replays of the call will be available as a webcast for three months in the investor area of the company's website at www.albmolecular.com/investor/investcc.html .

Founded in 1991, AMRI provides scientific services, technologies and products that improve quality of life while delivering excellence, value and maximum return. AMRI's core business consists of a fee-for service contract services platform encompassing drug discovery, development and manufacturing; and a separate, standalone R&D division comprising proprietary technologies, internal drug discovery and bundled capabilities designed for more collaborative relationships. With locations in the U.S. , Europe, and Asia , AMRI provides customers with a range of services and cost models.


Media Contact
David Albert, Director of Communications, 518-464-0279, ext. 2229

Investor Contact
P. Curtis Schenck, Investor Relations Manager, 518-464-0279, ext. 2933

Return to Main Press Release Page

Albany Molecular Research.
All Rights Reserved.